Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IPBNX vs. VPMCX: which is better?

Bottom line

IPBNX vs VPMCX: the short answer

IPBNX (Allspring Real Return Fund) and VPMCX (Vanguard PRIMECAP Fund) are both mutual funds.

But VPMCX is far broader, holding 173 positions to 1 for IPBNX, so beyond the top names it adds exposure IPBNX doesn't have.

VPMCX is cheaper at 0.35% vs 0.45% — a difference of $10.00 a year per $10,000 invested.

Over five years, VPMCX returned +14.3% a year vs +4.4% for IPBNX.

Updated Nov 19, 2026

IPBNX vs VPMCX side by side

IPBNXVPMCX
TypeMutual fundMutual fund
Fund familyAllspringVanguard
CategoryLarge BlendLarge Blend
Expense ratio0.45%0.35%
Annual cost per $10k$45$35
10-yr cost on $10k (prospectus)$803$443
Max front load0%0%
12b-1 fee0%0%
1-yr return+11.2%+29.9%
5-yr return (annualized)+4.4%+14.3%
10-yr return (annualized)+4.7%+15.2%
Best quarter—+17.3%
Worst quarter—−20.2%
Net assets (fund)$219.8M$96.1B
Number of holdings1173
Portfolio turnover59%11%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

IPBNX and VPMCX share none of their top holdings.

IPBNX top 10

  1. Allspring Real Return Portfolio — 99.71%

VPMCX top 10

  1. Micron Technology Inc — 13.50%
  2. Intel Corp — 6.80%
  3. Eli Lilly & Co — 6.76%
  4. KLA Corp — 3.85%
  5. Alphabet Inc — 3.52%
  6. AstraZeneca PLC — 2.35%
  7. NVIDIA Corp — 2.33%
  8. Amazon.com Inc — 2.05%
  9. Tesla Inc — 1.89%
  10. Biogen Inc — 1.88%

FAQ

What is the difference between IPBNX and VPMCX?
IPBNX (Allspring Real Return Fund) and VPMCX (Vanguard PRIMECAP Fund) are both mutual funds. But VPMCX is far broader, holding 173 positions to 1 for IPBNX, so beyond the top names it adds exposure IPBNX doesn't have.
Which is cheaper, IPBNX or VPMCX?
VPMCX has the lower expense ratio (0.35%).
Should I own both IPBNX and VPMCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.